HealthPartners Institute | MedPath Search

Found 196 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "HealthPartners Institute"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

De-Implementing Opioids for Dental Extractions

Not Applicable

Completed

Conditions: Tooth Extraction

Interventions: Other: Clinical Decision Support
Other: Patient education

First Posted Date: 2018-07-12

Last Posted Date: 2022-08-30

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 5722

Registration Number: NCT03584789

Locations: 🇺🇸
HealthPartners Dental Group, Bloomington, Minnesota, United States

Clinical Decision Support for Opioid Use Disorders in Medical Settings: Usability Testing in an EMR

Not Applicable

Completed

Conditions: Opioid-use Disorder

Interventions: Other: Opioid Wizard

First Posted Date: 2018-06-18

Last Posted Date: 2020-03-17

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 55

Registration Number: NCT03559179

Locations: 🇺🇸
HealthPartners, Bloomington, Minnesota, United States

In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old

Not Applicable

Completed

Conditions: Ear Infection
Otitis Media

Interventions: Device: Hummingbird Tympanostomy Tube System (H-TTS)

First Posted Date: 2018-06-01

Last Posted Date: 2022-12-14

Lead Sponsor: Preceptis Medical, Inc.

Target Recruit Count: 258

Registration Number: NCT03544138

Locations: 🇺🇸
Cedars-Sinai Medical Care Foundation, Beverly Hills, California, United States
🇺🇸
Children's Ear Nose Throat & Allergy, Orlando, Florida, United States
🇺🇸
HealthPartners Institute, Bloomington, Minnesota, United States

and more 4 locations

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

Phase 2

Terminated

Conditions: Mesothelioma, Malignant

Interventions: Drug: Nivolumab
Drug: Ramucirumab

First Posted Date: 2018-04-19

Last Posted Date: 2024-05-14

Lead Sponsor: Arkadiusz Z. Dudek, MD

Target Recruit Count: 34

Registration Number: NCT03502746

Locations: 🇺🇸
HealthPartners Institute Regions Cancer Care Center, Minneapolis, Minnesota, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States

and more 1 locations

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Phase 2

Active, not recruiting

Conditions: Colorectal Neoplasms
Exocrine Pancreatic Cancer
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell of Head and Neck

Interventions: Drug: tisotumab vedotin
Drug: pembrolizumab
Drug: carboplatin
Drug: cisplatin

First Posted Date: 2018-04-02

Last Posted Date: 2025-05-13

Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Target Recruit Count: 352

Registration Number: NCT03485209

Locations: 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸
UC San Diego / Moores Cancer Center, La Jolla, California, United States
🇺🇸
Stanford Cancer Center / Blood and Marrow Transplant Program, San Jose, California, United States

and more 69 locations

Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners

Not Applicable

Completed

Conditions: Irritant Contact Dermatitis

Interventions: Other: Skin Testing of Hair cleansing products

First Posted Date: 2018-03-29

Last Posted Date: 2019-02-25

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 200

Registration Number: NCT03483025

Locations: 🇺🇸
Park Nicollet Contact Dermatitis Clinic, Minneapolis, Minnesota, United States

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Phase 2

Completed

Conditions: Advanced Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma

Interventions: Drug: CB-839
Drug: Cabozantinib
Drug: Placebo

First Posted Date: 2018-02-09

Last Posted Date: 2023-03-20

Lead Sponsor: Calithera Biosciences, Inc

Target Recruit Count: 444

Registration Number: NCT03428217

Locations: 🇺🇸
NorthShore University HealthSystem, Evanston, Illinois, United States
🇺🇸
Orchard Healthcare Research, Inc., Skokie, Illinois, United States
🇺🇸
University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States

and more 129 locations

Evaluation of a Quality Improvement Project on Impacted Fetal Head at Cesarean Section

Completed

Conditions: Obstetric Labor Complications
Cesarean Section

Interventions: Other: Quality Improvement Project

First Posted Date: 2018-01-02

Last Posted Date: 2024-11-21

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 409

Registration Number: NCT03387189

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States

Esophageal Food Impaction

Phase 4

Completed

Conditions: Esophageal Food Bolus Obstruction

Interventions: Drug: Nitrostat 0.4Mg Sublingual Tablet

First Posted Date: 2017-10-10

Last Posted Date: 2023-02-08

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 20

Registration Number: NCT03305848

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

Phase 2

Terminated

Conditions: Urothelial Carcinoma

Interventions: Drug: Atezolizumab
Drug: Bevacizumab

First Posted Date: 2017-09-05

Last Posted Date: 2025-01-07

Lead Sponsor: Arjun Balar, MD

Target Recruit Count: 16

Registration Number: NCT03272217

Locations: 🇺🇸
University of Arizona at Dignity Health St. Joseph, Phoenix, Arizona, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
HealthPartners Institute, Minneapolis, Minnesota, United States

and more 5 locations